Katherine E Pillote, MD Internal Medicine - Endocrinology, Diabetes & Metabolism Medicare: Accepting Medicare Assignments Practice Location: 1900 Centracare Circle, St Cloud, MN 56303 Phone: 320-229-5000 Fax: 320-229-5184 |
Christopher Kim Balkany, MD Internal Medicine - Endocrinology, Diabetes & Metabolism Medicare: Not Enrolled in Medicare Practice Location: 2008 13th St S., St Cloud, MN 56301 Phone: 320-259-4449 |
Susan D Atamian, MD Internal Medicine - Endocrinology, Diabetes & Metabolism Medicare: Not Enrolled in Medicare Practice Location: 1900 Centracare Circle, St Cloud, MN 56303 Phone: 320-229-5000 Fax: 320-229-5184 |
Sindhu M. Devani, MD Internal Medicine - Endocrinology, Diabetes & Metabolism Medicare: Not Enrolled in Medicare Practice Location: 1900 Centracare Dr #2500, Centracare Clinic- Health Plaza Specialties/endocrinolo, St Cloud, MN 56303 Phone: 320-229-5000 |
News Archive
Integrated Document Solutions, a pioneer in delivering healthcare information and applications via cloud computing since 2003, today released the latest version of its AbbaDox modular healthcare workflow and documentation portal, featuring cross-platform compatibility and a new streamlined user interface. It is the company's fifth-generation cloud computing solution.
The University of Alabama in Huntsville College of Nursing has formed a new Learning and Technology Resource Center (LTRC) to consolidate its use of technology and lifelike patient simulators to train students and to further research in healthcare simulation education.
Researchers in the United States and India have conducted a study demonstrating the real-world effectiveness of a single dose of Johnson & Johnson's Ad26.COV2.S vaccine at preventing infection with severe acute respiratory syndrome coronavirus 2 – the agent that causes coronavirus disease 2019 (COVID-19).
Bristol-Myers Squibb Company and The University of Texas MD Anderson Cancer Center today announced a novel clinical research collaboration to evaluate multiple immunotherapies, including Opdivo (nivolumab), Yervoy (ipilimumab) and three early-stage clinical immuno-oncology assets from Bristol-Myers Squibb, as potential treatment options for acute and chronic leukemia as well as other hematologic malignancies.
› Verified 6 days ago